Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Melicent C. Peck"'
Autor:
Michael, Waters, James A, McKinnell, Andre C, Kalil, Greg S, Martin, Timothy G, Buchman, Wiebke, Theess, Xiaoying, Yang, Annemarie N, Lekkerkerker, Tracy, Staton, Carrie M, Rosenberger, Rajita, Pappu, Yehong, Wang, Wenhui, Zhang, Logan, Brooks, Dorothy, Cheung, Joshua, Galanter, Hubert, Chen, Divya, Mohan, Melicent C, Peck
Publikováno v:
Critical Care Medicine. 51:103-116
Severe cases of COVID-19 pneumonia can lead to acute respiratory distress syndrome (ARDS). Release of interleukin (IL)-33, an epithelial-derived alarmin, and IL-33/ST2 pathway activation are linked with ARDS development in other viral infections. IL-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a07e031bf85b5800f7352d5492dabc05
https://doi.org/10.1097/ccm.0000000000005716
https://doi.org/10.1097/ccm.0000000000005716
Autor:
Yi Cao, Alessander O Guimaraes, Melicent C Peck, Oleg Mayba, Felicia Ruffin, Kyu Hong, Montserrat Carrasco‐Triguero, Vance G Fowler Jr, Stacey A Maskarinec, Carrie M Rosenberger
Publikováno v:
Clinical & Translational Immunology, Vol 9, Iss 2, Pp n/a-n/a (2020)
Abstract Objectives To identify risk stratification biomarkers to enrich for the subset of Staphylococcus aureus bacteraemia patients who develop deep‐seated tissue infections with high morbidity and mortality to guide clinical trial enrolment and
Externí odkaz:
https://doaj.org/article/b25c6f8a31d440e3ac9bfc5b26d83a45
Autor:
Jacqueline McBride, Melicent C. Peck, Priscilla Horn, Priya Kulkarni, Jeremy J. Lim, Jorge A. Tavel, Gaohong She, Rong Deng, Aide Castro, Elizabeth M. Newton, William D. Hanley, Mauricio Maia
Publikováno v:
Journal of Clinical Pharmacology
MHAA4549A is a human anti‐influenza A monoclonal antibody developed to treat influenza A. We report MHAA4549A serum, nasopharyngeal, and tracheal aspirate pharmacokinetics from a phase 2b study in hospitalized patients with severe influenza A. Pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::162e5620d2382dd138b80b5267261979
https://doi.org/10.1002/jcph.1652
https://doi.org/10.1002/jcph.1652
Autor:
Priscilla Horn, Nimer Assy, Jacqueline McBride, Jeremy J. Lim, Rong Deng, Anna Nilsson, Joshua Galanter, Jorge A. Tavel, Allen Nguyen, Mauricio Maia, Melicent C. Peck, Xiaoying Yang, Aide Castro, Elizabeth M. Newton, Michael Silverman, Tom Chu, Chloe Li, Priya Kulkarni
Publikováno v:
Antimicrobial Agents and Chemotherapy
For patients hospitalized with severe influenza A virus infection, morbidity and mortality remain high. MHAA4549A, a human monoclonal antibody targeting the influenza A virus hemagglutinin stalk, has demonstrated pharmacological activity in animal st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5a2d1db715770bc77477b161f443a3d
https://doi.org/10.1128/aac.00352-20
https://doi.org/10.1128/aac.00352-20
Autor:
Vance G. Fowler, Carrie M. Rosenberger, Kyu Hong, Yi Cao, Felicia Ruffin, Alessander O Guimaraes, Montserrat Carrasco-Triguero, Oleg Mayba, Melicent C. Peck, Stacey A. Maskarinec
Publikováno v:
Clinical & Translational Immunology, Vol 9, Iss 2, Pp n/a-n/a (2020)
Objectives To identify risk stratification biomarkers to enrich for the subset of Staphylococcus aureus bacteraemia patients who develop deep‐seated tissue infections with high morbidity and mortality to guide clinical trial enrolment and clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0079194a20e0b5a3f49e5e1b6a2af365
https://doi.org/10.1002/cti2.1110
https://doi.org/10.1002/cti2.1110
Autor:
Yi, Cao, Alessander O, Guimaraes, Melicent C, Peck, Oleg, Mayba, Felicia, Ruffin, Kyu, Hong, Montserrat, Carrasco-Triguero, Vance G, Fowler, Stacey A, Maskarinec, Carrie M, Rosenberger
Publikováno v:
Clinical & Translational Immunology
Objectives To identify risk stratification biomarkers to enrich for the subset of Staphylococcus aureus bacteraemia patients who develop deep‐seated tissue infections with high morbidity and mortality to guide clinical trial enrolment and clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::72774ba2dd5203da3c9958067c059cef
https://pubmed.ncbi.nlm.nih.gov/32082571
https://pubmed.ncbi.nlm.nih.gov/32082571
Autor:
Angelo Clemenzi-Allen, Jason B Dinoso, Amos Baruch, Oleg Mayba, Alessander O Guimaraes, Carrie M. Rosenberger, Melicent C. Peck, Yi Cao, Kyu Hong, Montserrat Carrasco-Triguero, Henry F. Chambers, Johnny Gutierrez, Stacey A. Maskarinec, Catherine A. Koss, Vance G. Fowler, Felicia Ruffin
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol 68, iss 9
BACKGROUND: Staphylococcus aureus is a leading cause of bacteremia, yet there remains a significant knowledge gap in the identification of relevant biomarkers that predict clinical outcomes. Heterogeneity in the host response to invasive S. aureus in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3af5e8aab5d5727c2cb3541a8017912
https://escholarship.org/uc/item/4zm1f9qx
https://escholarship.org/uc/item/4zm1f9qx
Autor:
Carrie M. Rosenberger, Montserrat Carrasco-Triguero, Kyu Hong, Vance G. Fowler, Felicia Ruffin, Alessander O Guimaraes, Melicent C. Peck, Yi Cao, Amos Baruch, Stacey A. Maskarinec, Johnny Gutierrez
Publikováno v:
Open Forum Infectious Diseases
Background Staphylococcus aureus is a leading global cause of bacteremia that can cause invasive tissue infections with high morbidity and mortality despite appropriate antibiotic therapy. Clinicians lack sufficient tools to rapidly identify patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9cba42d37d03606fd7fb1714d4d3d42
https://doi.org/10.1093/ofid/ofz126
https://doi.org/10.1093/ofid/ofz126
Autor:
Henry F. Chambers, Nicholas Lewin-Koh, Jason B Dinoso, Carrie M. Rosenberger, Catherine A. Koss, Joanna K Chang, Alessander O Guimaraes, Melicent C. Peck, Johnny Gutierrez, Janice Kim, Min Xu, Amos Baruch, Angelo Clemenzi-Allen, Donghong Yan, Yi Cao, Aklile Berhanu
Publikováno v:
Open Forum Infectious Diseases. 6
Background Staphylococcus aureus (SA) bacteremia often requires a long treatment duration with antibiotics to prevent relapse due to the ability of SA to establish reservoirs of infection in sites such as heart and bone. These metastatic sites of inf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a927b6e7d4546cb85b8d13385c6f2ef6
https://doi.org/10.1093/ofid/ofz090
https://doi.org/10.1093/ofid/ofz090
Autor:
Carrie C Rosenberger, Jeremy J. Lim, Sharon M Rymut, Nicholas Lewin-Koh, Loren G. Miller, José M. Miró, Wouter L. W. Hazenbos, Melicent C. Peck, Vance G. Fowler, Montserrat Carrasco-Triguero, Jessica Couch, Tom Chu, Aklile Berhanu
Publikováno v:
Open Forum Infectious Diseases
Background New treatment approaches for complicated Staphylococcus aureus bacteremia (SAB) are needed. DSTA4637S is a THIOMABTM antibody-antibiotic conjugate consisting of an engineered human IgG1 monoclonal antibody that binds to wall teichoic acid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4400742316af5cff145b2d97d5424e69
https://doi.org/10.1093/ofid/ofaa439.477
https://doi.org/10.1093/ofid/ofaa439.477